Want to see HK:3689 full AI Analyst Report?
3689 Stock Chart & Stats
HK$1.88
HK$0.01(0.53%)
At close: 4:00 PM EDT
HK$1.88
HK$0.01(0.53%)
Day’s Range― - ―
52-Week RangeHK$0.91 - HK$2.30
Previous CloseN/A
Volume800.00
Average Volume (3M)1.02K
Market Cap
HK$672.13M
Enterprise ValueHK$634.42M
Total Cash (Recent Filing)HK$743.33M
Total Debt (Recent Filing)HK$326.21M
Price to Earnings (P/E)6.0
Beta0.15
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield9.45%
Share Statistics
EPS (TTM)0.29
Shares Outstanding84,394,000
10 Day Avg. Volume720
30 Day Avg. Volume1,020
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.34
Price to Sales (P/S)0.26
P/FCF Ratio2.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Profitability ReboundA meaningful margin recovery in 2025 signals improved operational control and pricing or mix benefits. Sustained mid-single-digit EBIT/net margins increase cash available for reinvestment, debt service and dividends, supporting financial resilience over the next several quarters.
Strong Cash GenerationConsistently positive operating and free cash flow provides durable internal funding for capex, working capital and shareholder returns. Even with volatility, multi-hundred-million FCF in 2025 gives management flexibility to reduce leverage or fund strategic investments over 2–6 months.
Improved Leverage And Balance SheetA materially lower debt-to-equity ratio enhances financial flexibility and reduces refinancing and interest-rate strain risk. This healthier capital structure supports capacity to absorb demand shocks, pursue selective investments, and maintain operations across the medium term.
Bears Say
Uneven Revenue TrendsDeclining and inconsistent top-line growth weakens predictability of margins and cash flow. For a hospital services business, volatile revenue suggests variability in patient volumes or reimbursement, complicating resource planning and long-term service expansion decisions.
Cash Flow VolatilityA sharp FCF drop and recurring volatility reduce reliability of internal funding for capex, dividends, or deleveraging. This increases the chance management must cut spending or seek external financing during adverse periods, raising execution risk over the coming months.
Quality-of-earnings RiskPast loss and abrupt earnings swings point to episodic operational or non-recurring items that can distort reported profitability. This history reduces confidence in the sustainability of the recent rebound and warrants caution when projecting earnings durability.
Guangdong Kanghua Healthcare Co., Ltd. Class H News
3689 FAQ
What was Guangdong Kanghua Healthcare Co., Ltd. Class H’s price range in the past 12 months?
Guangdong Kanghua Healthcare Co., Ltd. Class H lowest stock price was HK$0.91 and its highest was HK$2.30 in the past 12 months.
What is Guangdong Kanghua Healthcare Co., Ltd. Class H’s market cap?
Guangdong Kanghua Healthcare Co., Ltd. Class H’s market cap is HK$672.13M.
When is Guangdong Kanghua Healthcare Co., Ltd. Class H’s upcoming earnings report date?
Guangdong Kanghua Healthcare Co., Ltd. Class H’s upcoming earnings report date is Sep 01, 2026 which is in 27 days.
How were Guangdong Kanghua Healthcare Co., Ltd. Class H’s earnings last quarter?
Guangdong Kanghua Healthcare Co., Ltd. Class H released its earnings results on Mar 31, 2026. The company reported HK$0.19 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.19.
Is Guangdong Kanghua Healthcare Co., Ltd. Class H overvalued?
According to Wall Street analysts Guangdong Kanghua Healthcare Co., Ltd. Class H’s price is currently Overvalued.
Does Guangdong Kanghua Healthcare Co., Ltd. Class H pay dividends?
Guangdong Kanghua Healthcare Co., Ltd. Class H pays a Annually dividend of HK$0.19 which represents an annual dividend yield of 9.45%. See more information on Guangdong Kanghua Healthcare Co., Ltd. Class H dividends here
What is Guangdong Kanghua Healthcare Co., Ltd. Class H’s EPS estimate?
Guangdong Kanghua Healthcare Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Guangdong Kanghua Healthcare Co., Ltd. Class H have?
Guangdong Kanghua Healthcare Co., Ltd. Class H has 84,394,000 shares outstanding.
What happened to Guangdong Kanghua Healthcare Co., Ltd. Class H’s price movement after its last earnings report?
Guangdong Kanghua Healthcare Co., Ltd. Class H reported an EPS of HK$0.19 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Guangdong Kanghua Healthcare Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:3689
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Guangdong Kanghua Healthcare Co., Ltd. Class H Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-1.06%
12-Months-Change
Fundamentals
Return on Equity
9.45%
Trailing 12-Months
Asset Growth
2.27%
Trailing 12-Months
Company Description
Guangdong Kanghua Healthcare Co., Ltd. Class H
Guangdong Kanghua Healthcare Group Co., Ltd. primarily operates private hospitals in the People's Republic of China. The company operates through four segments: Hospital Services, Rehabilitation and Other Healthcare Services, Haemodialysis Services, and Elderly Healthcare Services. It provides inpatient and outpatient healthcare, and physical examination services. The company also offers reproductive medicine; plastic and aesthetic surgery; and laser treatment services. In addition, it provides rehabilitation services to patients with physical or mental disabilities; treatments that replicate kidney's function to remove wastes in blood for patients with kidney conditions; and other healthcare-related services, including elderly care and training service for the disabled. Further, the company offers elderly healthcare services, including assisted living, adult daycare, long-term care, residential care, and hospice care to the aged patients. Additionally, it operates Kanghua Hospital, Renkang Hospital, and Kangxin Hospital names; and offers management, hospital management, and property holding services. Guangdong Kanghua Healthcare Group Co., Ltd. was formerly known as Guangdong Kanghua Healthcare Co., Ltd. and changed its name to Guangdong Kanghua Healthcare Group Co., Ltd. in August 2024. The company was incorporated in 2002 and is based in Dongguan, China. Guangdong Kanghua Healthcare Group Co., Ltd. operates as a subsidiary of Dongguan Kanghua Investment Group Co., Ltd.
Technical Analysis
EuroEyes International Eye Clinic Limited
―
Chaoju Eye Care Holdings Ltd.
―
C-MER Eye Care Holdings Limited
―
Town Health International Medical Group Ltd.
―
Arrail Group Ltd.
―